QC
FULC icon

Quadrature Capital’s Fulcrum Therapeutics FULC Stock Holding History

Quadrature Capital’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$692K Buy
+189,119
New +$1.15M 0.01% 879

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Quadrature Capital's FULC Position: Q2 2026 in Review

Quadrature Capital opened a new position in Fulcrum Therapeutics (FULC) in Q2 2026: 189,119 shares worth $692K. The stake represents 0.01% of the portfolio and ranks #879 among its holdings.

43 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Quadrature Capital held 189,119 shares of Fulcrum Therapeutics worth $692K as of Q2 2026.
  • Fulcrum Therapeutics was a new Quadrature Capital position in Q2 2026.
  • Fulcrum Therapeutics made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #879 holding.
  • 43 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.